A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/20/2011	US20110257251 Telomerase inhibitors and methods of use thereof
10/20/2011	US20110257250 Treating Insulin Secreting Cells
10/20/2011	US20110257249 Drug carriers
10/20/2011	US20110257248 RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
10/20/2011	US20110257247 Method of Treating Neurodegenerative Disease
10/20/2011	US20110257246 RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
10/20/2011	US20110257245 Methods of identifying regulators of cellular proteostasis
10/20/2011	US20110257244 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof
10/20/2011	US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011	US20110257242 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257241 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257240 Stabilized statin formulations
10/20/2011	US20110257239 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257237 Process for the preparation of crystalline forms of sunitinib malate
10/20/2011	US20110257236 Solid solution of valine, isoleucine, leucine and its manufacturing method
10/20/2011	US20110257235 Triazolium and imidazolium salts and uses thereof
10/20/2011	US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257231 Anthranilamide compounds, process for their production and pesticides containing them
10/20/2011	US20110257230 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257229 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/20/2011	US20110257228 Liquid pharmaceutical compositions comprising a triptan compound and xylitol
10/20/2011	US20110257227 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
10/20/2011	US20110257225 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
10/20/2011	US20110257224 Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257221 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257220 3,11 b-cis-Dihydrotetrabenazine for the Treatment of Schizophrenia and Other Psychoses
10/20/2011	US20110257219 Lower dosage strength pharmaceutical compositions forumlated with 3.75% imiquimod
10/20/2011	US20110257218 2 x 2 x 2 WEEK DOSING REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 3.75 % IMIQUIMOD
10/20/2011	US20110257217 3 x 3 x 3 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD
10/20/2011	US20110257216 2 x 2 x 2 WEEK TREATMENT REGIMEN FOR TREATING ACTINIC KERATOSIS WITH PHARMACEUTICAL COMPOSITIONS FORMULATED WITH 2.5% IMIQUIMOD
10/20/2011	US20110257215 Novel co-crystal of tiotropium bromide
10/20/2011	US20110257214 Morphinan compounds
10/20/2011	US20110257213 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/20/2011	US20110257212 New azacyclic derivatives
10/20/2011	US20110257211 Small-Molecule Choline Kinase Inhibitors as Anti-Cancer Therapeutics
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257209 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257207 Raf inhibitors
10/20/2011	US20110257206 Combinations of Therapeutic Agents for Treating Cancer
10/20/2011	US20110257205 Xanthine derivatives as selective hm74a agonists
10/20/2011	US20110257204 Penciclovir or Famciclovir for Treatment of Recurrent Genital Herpes with a One-Day Application
10/20/2011	US20110257203 Inhibitors of bruton's tyrosine kinase
10/20/2011	US20110257202 Therapeutic Compositions and Methods for Treating Chronic Kidney Disease Associated with a Metabolic Imbalance
10/20/2011	US20110257201 Agent for overcoming resistance to anti-cancer agent
10/20/2011	US20110257200 Treatment of Acne and Other Diseases
10/20/2011	US20110257199 Novel teraryl compounds as antiparasitic agents
10/20/2011	US20110257198 Piperidine derivatives useful as orexin antagonists
10/20/2011	US20110257197 Pharmaceutical Formulations Comprising Voriconazole and Processes for Preparation Thereof
10/20/2011	US20110257196 Compounds for treatment of cancer
10/20/2011	US20110257194 Substituted oxindol derivatives and medicaments containing the same
10/20/2011	US20110257193 Fused imidazole derivatives as trpv3 antagonist
10/20/2011	US20110257192 Compound for treatment of respiratory condition or disease
10/20/2011	US20110257190 Crystalline forms
10/20/2011	US20110257189 Pyrrolopyrazinone inhibitors of kinases
10/20/2011	US20110257188 Compositions and methods for the treatment of nasal conditions
10/20/2011	US20110257187 Phthalazin-(2h)-one inhibitors of kinases
10/20/2011	US20110257186 Compositions and methods for treating visual disorders
10/20/2011	US20110257185 Reverse-turn mimetics and method relating thereto
10/20/2011	US20110257184 Shp-2 phosphatase inhibitor
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/20/2011	US20110257182 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257181 Pyridazinone derivatives
10/20/2011	US20110257180 Novel Polymorphic Forms of 6-(1-methyl-1H-pyrazol-4-yl)-2--2H-pyridazin-3-one Dihydrogenphosphate and Processes of Manufacturing thereof
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257175 Selected Inhibitors of Protein Tyrosine Kinase Activity
10/20/2011	US20110257174 Chromenone analogs as sirtuin modulators
10/20/2011	US20110257173 3 (3-Pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives
10/20/2011	US20110257172 3-(3-Pyrimidine-2-yl-benzyl)-[1,2,4] triazolo[4,3-b]pyrimidine derivatives
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257168 Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
10/20/2011	US20110257167 Identification of lkb1 mutation as a predictive biomarker for sensitivity to tor kinase inhibitors
10/20/2011	US20110257165 Bicyclic pyrazoles as protein kinase inhibitors
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257163 Gamma secretase modulators
10/20/2011	US20110257162 Hiv integrase inhibitors
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257160 Quinoline derivatives and uses thereof
10/20/2011	US20110257159 Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
10/20/2011	US20110257158 Precompacted fast-disintegrating formulations of compounds with a low oral bioavailability
10/20/2011	US20110257157 Thiolactams and uses thereof
10/20/2011	US20110257156 Gamma secretase modulators
10/20/2011	US20110257155 Compounds and compositions as protein kinase inhibitors
10/20/2011	US20110257154 Compounds and compositions as protein kinase inhibitors
10/20/2011	US20110257153 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
10/20/2011	US20110257152 Pyrrolopyridine inhibitors of kinases
10/20/2011	US20110257151 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	US20110257150 New salts
10/20/2011	US20110257149 Formulation for oral transmucosal administration of lipid-lowering drugs
10/20/2011	US20110257148 Novel 1-alkyl-3-hydroxy-3-phenylazetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257147 Neurotherapeutic treatment for sexual dysfunction

1 ... 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 ... 7860